Nerve Sheath Neoplasms - 25 Studies Found
Suspended |
: Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas :
|
Active, not recruiting |
: AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine :
: Drug: Cediranib Maleate Other Names: |
Recruiting |
: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors :
: 2015-10-21 :
|
Recruiting |
: Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain :
: 2015-06-12 : Other: Acceptance and Commitment Therapy (ACT) Acceptance and Commitment Therapy (ACT), a newer generati |
Active, not recruiting |
: Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +) :
|